Blog30 September 2024 Waiver of Consent vs Waiver of Written Consent One is very common, the other is rarely granted. Learn the key differences between waiver of consent &... Learn more
News8 February 2024 Castor collaborates with Microsoft to bring Practical AI to clinical trials. Today, Castor announces its collaboration with Microsoft to integrate Practical AI in clinical trials, reducing trial burdens for... Learn more
Video19 December 2023 2023: Castor Year in Review As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric... Learn more
Video24 November 2023 The AI Hype and Reality: Key Highlights from CNS Summit 2023 At this year's CNS Summit, Castor achieved a remarkable feat by winning the AI Demo Awards. Watch more... Learn more
Blog14 November 2023 10 FAQs on eConsent To gain a deeper understanding of eConsent, we have gathered the 10 most frequently asked questions that address... Learn more
Blog11 October 2023 Don’t Overengineer It: Hybrid Designs Overcome Barriers in DTx Clinical Trials At DTxEast 2023, Castor joined a panel discussion to answer big questions when designing DTx clinical trials Learn more
Video28 September 2023 Understand Barriers to eConsent Adoption from Site and Sponsor Perspectives Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges. Learn more
Webinar Navigating successful eConsent adoption from sponsor to site Our on demand webinar with Leanne Walsh from Northern Light Lifescience to dive into the process of eConsent... Learn more
Video24 August 2023 Harnessing the power of Patient-centric Technologies Decentralized technologies are transforming clinical trials by addressing patient recruitment and engagement challenges. Learn more
News21 August 2023 Castor announces Frans van Houten, former CEO of Philips, as the company’s new chairman of its Board Of Directors His exceptional leadership experience and extensive industry knowledge in the healthcare and technology industries will be invaluable to... Learn more
Blog14 August 2023 Preparing Your eConsent Study for IRB Approval In this blog we cover how eConsent benefits trials and aligns with IRB ethical commitments, how to prepare... Learn more
News3 July 2023 Castor welcomes Jeanne Hecht to Board of Directors Castor, an industry leader in modular, patient-centric, clinical trial technology, today announced the appointment of Jeanne Hecht to... Learn more
Video19 June 2023 AI & Air Hockey – What to expect at DIA? Listen to our CEO & Founder, Derk Arts, as he reflects on lessons learned from the BIO panel... Learn more
Webinar The role of patient-centric technologies & tokenization in RWE studies In this on-demand webinar we join forces with UBC & Datavant to dive deep into patient-centric technologies &... Learn more
Video24 April 2023 Considerations for the use of RWE in FDA Assessments As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these... Learn more
Video27 March 2023 Improving Your Consent Process with Generative AI As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these... Learn more
Video27 February 2023 Real-World Evidence: The Importance of Standardization & Democratization As the adoption of real-world evidence (RWE) in healthcare continues to grow, and with the FDA embracing these... Learn more
News1 February 2023 Castor announces appointment of Brad Hightower, leading clinical trials executive, to its advisory board Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board. Learn more
